For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

The Liposome Company, Inc.

Calculating rank

USPTO Granted Patents = 115

% Expired Patents = 1.7

CIPO Patents = 41

Forward Citations = 5,398

Loading Chart...

Loading Chart...

89 inventors (with patents filed for the assignee):

Andrew S Janoff (69 out of 80 patents)

Pieter Rutter Cullis (26 out of 73 patents)

Alan L Weiner (24 out of 26 patents)

4. Eric G Mayhew (21 out of 24 patents)

5. Mircea C Popescu (20 out of 24 patents)

6. Marcel B Bally (18 out of 48 patents)

7. Paul A Tremblay (16 out of 18 patents)

8. Imran Ahmad (14 out of 32 patents)

9. Robert P Lenk (13 out of 16 patents)

10. Michael W Fountain (13 out of 13 patents)

11. Michael J Hope (12 out of 40 patents)

12. J Craig Franklin (12 out of 13 patents)

13. Suresh K Bhatia (12 out of 12 patents)

14. Lois E Bolcsak (11 out of 11 patents)

15. Richard S Ginsberg (11 out of 11 patents)

Core Competencies:

Liposomal Drug Delivery

Hydrophobic Taxane Derivatives

Peptide-Lipid Conjugates

Low-Toxicity Formulations

Etherlipid Liposomes

Pharmaceutical Compositions

Antineoplastic Agents

Diagnostic Assays

Immunogenic Liposomes

Prostaglandin Formulations

Fusogenic Liposomes

Encapsulation Techniques

115 patents: Sort by Forward Citations

1. RE39042 - Etherlipid-containing multiple lipid liposomes (2006-03-27),

2. 6500461 - Particulate formulations (2002-12-31),

3. 6482850 - Hydrolysis-promoting hydrophobic taxane derivatives (2002-11-19),

4. 6406713 - Methods of preparing low-toxicity drug-lipid complexes (2002-06-18),

5. 6392063 - Hydrolysis-promoting hydrophobic taxane derivatives (2002-05-21),

6. 6352716 - Steroidal liposomes (2002-03-05),

7. 6294191 - N-acyl phosphatidylethanolamine-mediated liposomal drug delivery (2001-09-25),

8. 6291690 - Hydrophobic taxane derivatives (2001-09-18),

9. 6261792 - Lipid-dependent diagnostic assays (2001-07-17),

10. 6180137 - Etherlipid-containing multiple lipid liposomes (2001-01-30),

11. 6153736 - Modified ether glyceroglycolipids (2000-11-28),

12. 6143716 - Liposomal peptide-lipid conjugates and delivery using same (2000-11-07),

13. 6120797 - N-acyl phosphatidylethanolamine-mediated liposomal drug delivery (2000-09-19),

14. 6118011 - Preparation of liposomal taxanes (2000-09-12),

15. 6107332 - Hydrolysis-promoting hydrophobic taxane derivatives (2000-08-22),

Company Overview

The Liposome Company, Inc., based in Princeton, NJ, specializes in the development and manufacturing of innovative liposomal drug delivery systems. The company focuses on creating low-toxicity formulations and advanced pharmaceutical compositions that enhance the efficacy and safety of therapeutic agents, particularly hydrophobic taxane derivatives and antineoplastic agents. Their expertise extends to peptide-lipid conjugates and etherlipid liposomes, positioning them at the forefront of drug delivery technology and diagnostic assays.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

115 Patents

#19 in Princeton, NJ

#151 in New Jersey

#3,345 in US

#6,902 in the World

Princeton, NJ, United States of America

The Liposome Company, Inc.

Forward Citations = 5,398

89 inventors:

Andrew S Janoff (69 out of 80 patents)

Pieter Rutter Cullis (26 out of 73 patents)

Alan L Weiner (24 out of 26 patents)

4. Eric G Mayhew (21 out of 24 patents)

5. Mircea C Popescu (20 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Liposome Company, Inc.. Retrieved from https://idiyas.com/company/liposome-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…